In addition, Hu’s team showed that the lower expression of BECN1 was associated with a poor prognosis in CRC, suggesting that BECN1 may act as a suppressor and represent a new prognostic marker for patients with colorectal cancer. Here, BECN1 is linked to colorectal carcinoma.